market analyst, marketanalyst.net, market analyst llc, market research & analyst



Payment Options

You are here: Home > Publishers > GBI Research

GBI Research

GBI Research is a market-leading provider of business intelligence reports. GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders’ insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs. Headquartered in the UK, the company has branches in the US and Asia.

Sort By:
Page of 21
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Multiple Myeloma Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments Frontier Pharma: Obesity - Identifying and Commercializing First-in-Class Innovation
Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma
Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation
Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Americas
Market Digest: Ultrasound Systems Market 2006 to 2020 - Asia-Pacific Market Digest: Ultrasound Systems Market 2006 to 2020 - Europe Market Digest: Ultrasound Systems Market 2006 to 2020 - Americas
MRI Systems Market to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Asia-Pacific Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches
Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations Frontier Pharma: Alzheimers Disease - Identifying and Commercializing First-in-Class Innovation Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics
Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation Womens Health - Assessing the Need for a Targeted and Specialized Approach Frontier Pharma - Parkinson’s Disease - Identifying and Commercializing First-in-Class Innovation
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting Market Snapshot: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico) ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations